Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers

IHC-IDH 1 Antibody Test, Price, Normal Range | Sprint Diagnostics Hyderabad

The IHC-IDH 1 antibody diagnostic test is a significant tool in the field of medicine, particularly in neuro- oncology. This test identifies the presence of a mutated version of isocitrate dehydrogenase 1 (IDH1), an enzyme that is implicated in various forms of brain cancer. It is conducted on tissue samples, usually taken from the brain, which are then analyzed in the lab using special stains that react with the IDH1 antibody.

Understanding the status of the IDH1 mutation can be crucial for the diagnosis, prognosis, and treatment plan for diseases like gliomas and other forms of brain cancer. Mutations in the IDH1 gene are found in a significant portion of gliomas and are usually associated with a better prognosis than gliomas without these mutations. Moreover, the presence of an IDH1 mutation can influence treatment options, making this test a key part of managing these conditions.

  • Test Name: IHC-IDH 1 Antibody
  • Sample Type: Tissue
  • Preparations Required: No specific preparation is necessary before the test, but it's crucial to inform your healthcare provider about all your current medications and any existing health conditions.
  • Report Time: 3 days

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

The IHC-IDH 1 antibody test is crucial in detecting IDH1 mutations, which are common in several types of brain tumors, including gliomas. These mutations can have significant implications on prognosis and treatment options, making this test vital for optimal disease management.

No fasting is required before this test. It's essential to inform your healthcare provider about any medications you're taking as they could potentially affect the procedure or results.

This test is typically ordered when there's a clinical suspicion or confirmed diagnosis of a brain tumor. Your healthcare provider will recommend when this test should be done based on your symptoms and medical history.

This test measures the presence of a mutated IDH1 enzyme in tissue samples, which can be a marker for certain types of brain tumors.

The frequency of this test is based on your healthcare provider's recommendation. It's usually performed when there's a need to diagnose or monitor the progression of brain tumors, or to inform treatment decisions.

This test typically yields qualitative results, indicating either the presence or absence of the IDH1 mutation. Your healthcare provider will discuss what your specific results mean in the context of your overall health and condition.

No special precautions are needed for this test. However, it's always advisable to share any concerns or queries you may have with your healthcare provider.

IDH1 levels can be influenced by various factors. Some nonmodifiable factors include genetics and certain diseases like brain tumors. Modifiable factors could potentially include certain treatments and medications.

Abnormal test results should be discussed with a healthcare provider, typically a neuro-oncologist, who is experienced in treating brain tumors.

Always inform your healthcare provider about any medications you're taking. Some drugs might interfere with the test results or the procedure used to collect the tissue sample.

The test itself doesn't cause pain. However, the tissue sample collection process, which often involves a biopsy, might cause some discomfort. Your healthcare provider will take all necessary steps to minimize discomfort and ensure the procedure is as painless as possible.

Follow your healthcare provider's instructions regarding wound care and follow-up appointments. If you experience any unexpected side effects or complications, immediately seek medical help.

Yes, the IHC-IDH 1 antibody test is an accurate method for detecting IDH1 mutations in tissue samples. However, like any test, it should be interpreted in the context of other clinical information and diagnostic findings.

The turnaround time for this test generally varies from 7 to 10 days, depending on the laboratory and specific conditions.

Yes, this test can be performed on patients of any age if the healthcare provider considers it necessary. It's important to discuss any concerns about the test with your child's healthcare provider.

In conclusion, the IHC-IDH 1 antibody diagnostic test is a vital tool in the hands of healthcare providers, assisting them in making informed decisions about your health management plan. The complexity of the test shouldn't discourage you; the information it provides contributes significantly to personalized treatment strategies, ultimately aiming for the best possible outcome in disease management. Remember, this test should be considered as part of a wider diagnostic approach, and results should always be interpreted alongside other clinical findings.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet